The Effect of PVP Molecular Weight on Dissolution Behavior and Physicochemical Characterization of Glycyrrhetinic Acid Solid Dispersions

被引:18
作者
Sui, Xiaoyu [1 ]
Chu, Yan [1 ]
Zhang, Jie [1 ]
Zhang, Honglian [1 ]
Wang, Huiyu [1 ]
Liu, Tingting [1 ]
Han, Cuiyan [1 ]
机构
[1] Qiqihar Med Univ, Coll Pharm, Qiqihar 161006, Peoples R China
关键词
IN-VITRO; BIOAVAILABILITY ENHANCEMENT; CONVENTIONAL SOLVENT; DRUG-RELEASE; SOLUBILITY; MECHANISMS; CARRIERS; SYSTEMS; K-30;
D O I
10.1155/2020/8859658
中图分类号
TQ [化学工业];
学科分类号
0817 ;
摘要
The effect of polyvinylpyrrolidone (PVP) as glycyrrhetic acid (GA) solid dispersions carrier at different molecular weights on the dissolution behavior and physicochemical properties was investigated. PVP-GA-SDs prepared with all four molecular weight PVPs displayed good enhancement of dissolution rate and equilibrium solubility compared with pure drug and corresponding physical mixtures. The results showed that the enhancement effect of molecular weight on dissolution rate and equilibrium solubility follows PVP K30PVP K60PVP K17PVP K15. In addition, the dissolution rate and solubility of the SDs with a carrier-drug ratio of 8 : 1 were better than the samples of 4 : 1. The DSC and XRD patterns showed that the crystallization of GA in SDs prepared by PVP K30 and PVP K60 was significantly inhibited, and both were transformed to amorphous. Based on FTIR and Raman detection, a hydrogen-bond between PVP and drug molecules is formed. SEM results showed that there were no significant differences in the appearance of SDs prepared with four PVPs, and no crystalline morphology of GA was seen. In conclusion, the findings of this study demonstrated that the dissolution performance of the PVP-GA-SDs prepared by the solvent method is related to the molecular weight of PVP, and the change in the molecular weight of PVP does not cause a monotonic change in dissolution of GA. The samples with PVP K30 as the carrier have the best dissolution performance.
引用
收藏
页数:13
相关论文
共 42 条
[1]   INTESTINAL BACTERIAL HYDROLYSIS IS INDISPENSABLE TO ABSORPTION OF 18-BETA-GLYCYRRHETIC ACID AFTER ORAL-ADMINISTRATION OF GLYCYRRHIZIN IN RATS [J].
AKAO, T ;
HAYASHI, T ;
KOBASHI, K ;
KANAOKA, M ;
KATO, H ;
KOBAYASHI, M ;
TAKEDA, S ;
OYAMA, T .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1994, 46 (02) :135-137
[2]   Licorice: A possible anti-inflammatory and anti-ulcer drug [J].
Aly, AM ;
Al-Alousi, L ;
Salem, HA .
AAPS PHARMSCITECH, 2005, 6 (01) :E74-E82
[3]   Physicochemical Characterization of Hot Melt Extruded Bicalutamide-Polyvinylpyrrolidone Solid Dispersions [J].
Andrews, Gavin P. ;
Abudiak, Osama A. ;
Ones, David S. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 99 (03) :1322-1335
[4]   Cogrinding as an approach to enhance dissolution rate of a poorly water-soluble drug (gliclazide) [J].
Barzegar-Jalali, Mohammad ;
Valizadeh, Hadi ;
Shadbad, Mohammad-Reza Siahi ;
Adibkia, Khosro ;
Mohammadi, Ghobad ;
Farahani, Amin ;
Arash, Zeynab ;
Nokhodchi, Ali .
POWDER TECHNOLOGY, 2010, 197 (03) :150-158
[5]   Spring and parachute: How cocrystals enhance solubility [J].
Bavishi, Dhara D. ;
Borkhataria, Chetan H. .
PROGRESS IN CRYSTAL GROWTH AND CHARACTERIZATION OF MATERIALS, 2016, 62 (03) :1-8
[6]   Glycyrrhetinic Acid Mediated Drug Delivery Carriers for Hepatocellular Carcinoma Therapy [J].
Cai, Yuee ;
Xu, Yingqi ;
Chan, Hon Fai ;
Fang, Xiaobin ;
He, Chengwei ;
Chen, Meiwan .
MOLECULAR PHARMACEUTICS, 2016, 13 (03) :699-709
[7]   Design of PVP/VA S-630 based tadalafil solid dispersion to enhance the dissolution rate [J].
Choi, Jin-Seok ;
Park, Jeong-Sook .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 97 :269-276
[8]   The mechanisms of drug release from solid dispersions in water-soluble polymers [J].
Craig, DQM .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 231 (02) :131-144
[9]   DISPOSITION OF [C-14] POVIDONE AFTER ORAL-ADMINISTRATION TO THE RAT [J].
DIGENIS, GA ;
WELLS, DA ;
ANSELL, JM ;
BLECHER, L .
FOOD AND CHEMICAL TOXICOLOGY, 1987, 25 (03) :241-243
[10]   Mechanism and Improved Dissolution of Glycyrrhetinic Acid Solid Dispersion by Alkalizers [J].
Dong, Luning ;
Mai, Yaping ;
Liu, Qiang ;
Zhang, Wannian ;
Yang, Jianhong .
PHARMACEUTICS, 2020, 12 (01)